Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on ...

Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...

Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

The FDA commissioner said access to mifepristone will stay the same, despite ongoing reviews of safety data and pressure from ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. “As with all drugs, FDA continues to ...

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that ...